Skip to main content
VCbacked
Log inGet Started

Fulcrum Therapeutics

Cambridge, United States

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

$175.0M raised
Dec 2025
Post-IPO Equity
BiotechnologyGeneticsHealth CareTherapeutics

Top Investors

Perceptive AdvisorsForesite CapitalSanofiFidelitySamsara BioCapital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Fulcrum Therapeutics

How much funding has Fulcrum Therapeutics raised?
Fulcrum Therapeutics has raised $175.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Who are Fulcrum Therapeutics's investors?
Fulcrum Therapeutics's investors include Perceptive Advisors, Foresite Capital, Sanofi, Fidelity, Samsara BioCapital.
Where is Fulcrum Therapeutics headquartered?
Fulcrum Therapeutics is headquartered in Cambridge, United States.
What does Fulcrum Therapeutics do?
Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
What stage is Fulcrum Therapeutics at?
Fulcrum Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Fulcrum Therapeutics — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/fulcrum-therapeutics. Accessed July 4, 2026.
APA
VCBacked. (2025). Fulcrum Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/fulcrum-therapeutics
Wikipedia (cite web)
{{cite web |title=Fulcrum Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/fulcrum-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K